| NBRP Rat No: 1043 |
Strain name: LE-Oprm1em1(cre)Bfdi |
Commmon Name: |
|
| Principal Investigator: |
Yilong Cui RIKEN Center for Biosystems Dynamics Research Kobe 650-0047, Hyogo, Japan 650-0047 Japan |
| Tel: 078-304-7192 Fax: 078-304-7191 |
Email: cuiyl@riken.jp |
| Preservation Status: |
Embryo Sperm Living Animals |
 |
 |
| Coat Color |
|
| Inbred Generations |
F67 |
| Usage Restrictions |
In publishing, a citation of the following literatures designated by the DEPOSITOR is requested. <Name of literatures> Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia
|
| Genetic Status |
|
| Comercial Availability |
|
|
| Research Category |
|
| Gene Affected |
oprm1 |
| Origin |
The genetic background is Iar: Long-Evans (Institute for Animal Reproduction). Long-Evans rats were introduced from Monash University to Institute for Animal Experimentation, Tohoku University in 1984, and then to Institute for Animal Reproduction in 1996. These rats were generated with the support of the Advanced Animal Model Support. |
| Strain characteristics |
Cre gene expression is dependent on the Oprm1 gene promoter. |
| Breeding Conditions |
Good breeding performance |
| Genotyping |
Genotyping by PCR. Protocol 50mM NaOH 180μl 100℃ 20 min → 1M Tris-HCL(PH8) 20μl → vortex → Spin down → Move supernatant to new tube DNA 0.3μl KAPA2 5μl Primer Forward (10μM) 0.2μl(final 0.2μM) Primer Reverse (10μM) 0.2μl (final 0.2μM) dH2O 4.3μl 10μl
1. 94℃ 1 min 2. 98℃ 10 sec 3.60℃ 15 sec 4. 68℃ 30 sec step2-4 30cycles 5. 72℃ 10 min 6. 4℃ hold
2% Agarose gel 100V 25 minutes
Primer: F1: 5’-TGATGGCCCTCATTCTGAGC-3’ (R1) F2: 5’-GGCGCTAAGGATGACTCTGG-3’ (R2, 3) F3: 5’-TAGTTGCCAGCCATCTGTTG-3’ (F1) R1: 5’-TAACTACCTGTTTTGCCG GG-3’ (F2) R2: 5’-GACAGCAAGGGGGAGGAT-3’ (F2, 3) R3: 5’-ATGTGGGGGTTAGGAGAGGG -3’ |
| References |
H Neyama, Y Wu, Y Nakaya, S Kato, T Shimizu, T Tahara, M Shigeta, M Inoue, K Miyamichi, N Matsushita, T Mashimo, Y Miyasaka, Y Dai, K Noguchi, Y Watanabe, M Kobayashi, K Kobayashi, Y Cui
Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia
Sci Adv. 2025 Jan 17;11(3):eadp8494. |
| Additional strain information |
|
|